Clinical trial
Residual Inflammation and Plaque Progression Long-term Evaluation
NCT04073810 is registered in ClinicalTrials.gov with University of Cambridge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Residual Inflammation and Plaque Progression Long-term Evaluation
- Lead sponsor
- University of Cambridge
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2020
- Completion date
- April 1, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.